Abnormal Hepatic Echogenicity C4477001
An unusual appearance of liver tissue on ultrasound scans. It may indicate fatty deposits, inflammation, or other liver changes. Further testing helps determine the cause and appropriate care.
Key facts at a glance
- ICD-10
- K76.9
- ICD-11
- DA00.0
- Body system
- hepatobiliary
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Jaundice
Yellowing of the skin and whites of the eyes due to elevated bilirubin
Seek immediate medical care if jaundice appears, as it may indicate liver dysfunction
Mental Confusion
Difficulty concentrating, memory problems, or disorientation
Seek emergency care immediately if confusion develops suddenly, as it may indicate hepatic encephalopathy
Fatigue
(constitutional)Persistent tiredness and lack of energy that does not improve with rest
Frequency: 60-70% of patients
Right Upper Quadrant Discomfort
(gastrointestinal)Dull ache or fullness in the upper right abdomen where the liver is located
Frequency: 40-50% of patients
Loss of Appetite
(gastrointestinal)Reduced desire to eat, often accompanied by early satiety
Frequency: 35-45% of patients
Nausea
(gastrointestinal)Feeling of sickness with an urge to vomit
Frequency: 25-35% of patients
Abdominal Swelling
(gastrointestinal)Buildup of fluid in the abdomen causing visible distension
Frequency: 5-15% of patients
Spider Angiomas
(dermatologic)Small, visible blood vessels on the skin resembling spider webs
Frequency: 10-15% of patients
Dark Urine
(gastrointestinal)Urine that appears darker than usual, often amber or brown-colored
Frequency: 15-20% of patients
Easy Bruising
(dermatologic)Bruises appearing more easily due to reduced liver function affecting blood clotting
Frequency: 10-15% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Lifestyle modification and dietary intervention
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Regular Liver Ultrasound Monitoring
Scheduled follow-up imaging studies to track changes in hepatic echogenicity patterns over time. This allows clinicians to identify progression or resolution of the abnormality and guide further intervention.
Alcohol Cessation and Lifestyle Modification
Complete elimination of alcohol consumption combined with smoking cessation and regular exercise. These modifications reduce hepatic stress and support overall liver function recovery.
When to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Hepatic Echogenicity C4477001?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines on the management of fatty liver disease. J Hepatol. 2022;77(2):479-495.
Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77(5):1797-1835.
Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123(3):745-750.
Hernandez-Roman J, Martinez SD, Liu L, et al. Ultrasound-based quantitative scores for fatty liver disease: a meta-analysis. Hepatology. 2023;78(5):1554-1566.
American Gastroenterological Association. AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease. Gastroenterology. 2023;165(1):14-29.
Bedossa P, Patel K, Castera L. Histologic assessment of nonalcoholic fatty liver disease. Virchows Arch. 2021;479(3):511-523.
Joseph AE, Saverymuttu SH, al-Sam S, Cook MG, Maxwell JD. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol. 1991;43(1):26-31.
WHO. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva: World Health Organization; 2024.
Medication Comparisons
Compare medications used to treat Abnormal Hepatic Echogenicity C4477001. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy